Showing results (461-470 of 3,697) with videos related to
Sort By:
Pageof 370
International Journal of Clinical Oncology|June 6, 2018
Early recurrence after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)Grace Hwei Ching Tan, Claramae Shulyn Chia, Sze Huey Tan, et al.International Journal of Clinical Oncology|May 11, 2018
Current clinical topics of Lynch syndromeKohji TanakayaInternational Journal of Clinical Oncology|May 11, 2018
Rapid decrease of serum alpha-fetoprotein and tumor volume predicts outcome in children with hepatoblastoma treated with neoadjuvant chemotherapyRosa Nguyen, M Beth McCarville, April Sykes, et al.International Journal of Clinical Oncology|May 26, 2019
A phase II randomized controlled study of pegylated liposomal doxorubicin and carboplatin vs. gemcitabine and carboplatin for platinum-sensitive recurrent ovarian cancer (GOTIC003/intergroup study)Hiroyuki Fujiwara, Kimio Ushijima, Shoji Nagao, et al.International Journal of Clinical Oncology|May 11, 2019
Thrombotic events induce the worse prognosis in ovarian carcinomas and frequently develop in ovarian clear cell carcinomaKazuki Takasaki, Morikazu Miyamoto, Masashi Takano, et al.International Journal of Clinical Oncology|March 26, 2018
D-dimer predicts postoperative recurrence and prognosis in patients with liver metastasis of colorectal cancerAkira Watanabe, Kenichiro Araki, Norihumi Harimoto, et al.International Journal of Clinical Oncology|November 15, 2017
Selecting patients for hyperthermia combined with preoperative chemoradiotherapy for locally advanced rectal cancerSang-Won Kim, Ji Woon Yea, Jae Hwang Kim, et al.International Journal of Clinical Oncology|November 9, 2019
Impact of microscopically margin-positive resection on survival in children with hepatoblastoma after hepatectomy: a retrospective cohort studyXianghai Ren, Haibo Li, Mei Diao, et al.International Journal of Clinical Oncology|December 14, 2019
Prognostic significance of serum p53 antibody according to KRAS status in metastatic colorectal cancer patientsNobuya Daitoku, Yuji Miyamoto, Yuki Sakamoto, et al.International Journal of Clinical Oncology|December 16, 2019
Prognostic scores for evaluating the survival benefit of regorafenib or trifluridine/tipiracil in patients with metastatic colorectal cancer: an exploratory analysis of the REGOTAS studyToshikazu Moriwaki, Shota Fukuoka, Toshiki Masuishi, et al.Pageof 370